Institution
Agaplesion Markus Hospital
Also known as: Agaplesion Markus Krankenhaus
- 6running trials
- 5closed trials
- 2,087publications (OpenAlex)
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
Closed trials
Terminated
Completed
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Registry name variants (10)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Agaplesion Markus Krankenhaus
Frankfurt, 60431
5 trials
Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse 60431
5 trials
Agaplesion Markus Krankenhaus (Site 0904)
Frankfurt am Main, Hesse
1 trial
Agaplesion Markus Hospital
Frankfurt am Main, 60431
Agaplesion Markus Krankenhaus - Site #457
Frankfurt am Main, Hesse 60431
Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse 60431
Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse 60431
Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse 60431
Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse 60431
Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse 60431
Conditions
Diseases this institution publishes on or runs trials for.
- Ulcerative colitis26 works · 3 trials
Institution data: ROR 04hd04g86 (CC0-1.0)Updated 15 Nov 2026